ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 76 filers reported holding ALX ONCOLOGY HLDGS INC in Q2 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13,780,800 | -36.1% | 2,871,000 | 0.0% | 0.29% | -25.1% |
Q2 2023 | $21,561,210 | +66.2% | 2,871,000 | 0.0% | 0.39% | +53.3% |
Q1 2023 | $12,976,920 | -59.9% | 2,871,000 | 0.0% | 0.26% | -58.8% |
Q4 2022 | $32,356,170 | +17.8% | 2,871,000 | 0.0% | 0.62% | +21.4% |
Q3 2022 | $27,475,000 | +55.3% | 2,871,000 | +31.3% | 0.51% | +59.4% |
Q2 2022 | $17,687,000 | +68.3% | 2,186,269 | +251.7% | 0.32% | +88.2% |
Q1 2022 | $10,507,000 | +135.5% | 621,700 | +199.5% | 0.17% | +198.2% |
Q4 2021 | $4,461,000 | -59.7% | 207,600 | +38.4% | 0.06% | -53.3% |
Q3 2021 | $11,079,000 | +35.1% | 150,000 | 0.0% | 0.12% | +47.0% |
Q2 2021 | $8,202,000 | -25.8% | 150,000 | 0.0% | 0.08% | -19.4% |
Q1 2021 | $11,061,000 | -14.5% | 150,000 | 0.0% | 0.10% | -8.8% |
Q4 2020 | $12,930,000 | – | 150,000 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
venBio Partners LLC | 9,699,925 | $715,272,000 | 67.97% |
Logos Global Management LP | 3,156,981 | $232,796,000 | 22.72% |
Vivo Capital, LLC | 4,220,048 | $311,186,000 | 10.94% |
Foresite Capital Management IV, LLC | 785,945 | $57,956,000 | 6.94% |
Foresite Capital Management V, LLC | 320,000 | $23,597,000 | 6.94% |
Board of Trustees of The Leland Stanford Junior University | 518,822 | $38,258,000 | 3.38% |
Cormorant Asset Management, LP | 881,770 | $65,022,000 | 1.45% |
Redmile Group, LLC | 978,600 | $72,162,000 | 1.02% |
SPHERA FUNDS MANAGEMENT LTD. | 130,351 | $9,612,000 | 0.74% |
Artal Group S.A. | 525,000 | $38,714,000 | 0.68% |